Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $234,344 - $404,954
-49,026 Reduced 67.12%
24,012 $166,000
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $1.02 Million - $1.76 Million
73,038 New
73,038 $1.57 Million
Q1 2018

May 15, 2018

SELL
$2.99 - $4.44 $98,670 - $146,520
-33,000 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$3.06 - $4.09 $76,500 - $102,250
-25,000 Reduced 43.1%
33,000 $132,000
Q3 2017

Nov 14, 2017

BUY
$3.03 - $3.72 $172,710 - $212,040
57,000 Added 5700.0%
58,000 $203,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,000
1,000 $4,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $185M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.